7 Einträge gefunden

1. Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers.

   1. Shariat, Shahrokh F
   2. Karam, Jose A
   3. Walz, Jochen
   4. Roehrborn, Claus G
   5. Montorsi, Francesco
   6. Margulis, Vitaly
   7. Saad, Fred

   2008 - Forschungsinformationssystem des UKE
2. Baseline prevalence of erectile dysfunction in a prostate cancer screening population.

   1. Walz, Jochen
   2. Perrotte, Paul
   3. Suardi, Nazareno
   4. Hutterer, Georg
   5. Jeldres, Claudio
   6. Bénard, Francois
   7. Valiquette, Luc

   2008 - Forschungsinformationssystem des UKE
3. Early postoperative plasma transforming growth factor-beta1 is a strong predictor of biochemical progression after radical prostatectomy.

   1. Shariat, Shahrokh F
   2. Walz, Jochen
   3. Roehrborn, Claus G
   4. Montorsi, Francesco
   5. Jeldres, Claudio
   6. Saad, Fred
   7. Karakiewicz, Pierre I

   2008 - Forschungsinformationssystem des UKE
4. Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population.

   1. Walz, Jochen
   2. Nazareno, Suardi
   3. Hutterer, Georg C
   4. Perrotte, Paul
   5. Gallina, Andrea
   6. Bénard, Francois
   7. Valiquette, Luc

   2008 - Forschungsinformationssystem des UKE
5. The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: a population-based analysis of 9208 consecutive cases.

   1. Walz, Jochen
   2. Montorsi, Francesco
   3. Jeldres, Claudio
   4. Nazareno, Suardi
   5. Shariat, Shahrokh F
   6. Perrotte, Paul
   7. Arjane, Philippe

   2008 - Forschungsinformationssystem des UKE
6. Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.

   1. Jeldres, Claudio
   2. Suardi, Nazareno
   3. Walz, Jochen
   4. Saad, Fred
   5. Hutterer, Georg C
   6. Bhojani, Naeem
   7. Shariat, Shahrokh F

   2008 - Forschungsinformationssystem des UKE
7. Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.

   1. Walz, Jochen
   2. Haese, Alexander
   3. Scattoni, Vincenzo
   4. Steuber, Thomas
   5. Chun, Felix
   6. Briganti, Alberto
   7. Montorsi, Francesco

   2008 - Forschungsinformationssystem des UKE